113 related articles for article (PubMed ID: 12077687)
21. Release of cardiac biochemical and inflammatory markers in patients on cardiopulmonary bypass undergoing coronary artery bypass grafting.
Meng QH; Zhu S; Sohn N; Mycyk T; Shaw SA; Dalshaug G; Krahn J
J Card Surg; 2008; 23(6):681-7. PubMed ID: 18778302
[TBL] [Abstract][Full Text] [Related]
22. Minimal versus conventional cardiopulmonary bypass: assessment of intraoperative myocardial damage in coronary bypass surgery.
Immer FF; Pirovino C; Gygax E; Englberger L; Tevaearai H; Carrel TP
Eur J Cardiothorac Surg; 2005 Nov; 28(5):701-4. PubMed ID: 16221550
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
[TBL] [Abstract][Full Text] [Related]
24. ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Myles PS; Olenikov I; Bujor MA; Davis BB
Med J Aust; 1993 May; 158(10):675-7. PubMed ID: 8487686
[TBL] [Abstract][Full Text] [Related]
25. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
Gündüz F; Kuru O; Sentürk UK
Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
[TBL] [Abstract][Full Text] [Related]
27. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
28. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
30. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.
Mannacio VA; Iorio D; De Amicis V; Di Lello F; Musumeci F
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1541-8. PubMed ID: 19114204
[TBL] [Abstract][Full Text] [Related]
31. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M
Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551
[TBL] [Abstract][Full Text] [Related]
32. Bolus injection of adenosine before cardioplegic induction improves postischemic global function in coronary artery bypass grafting.
Chen CH; Kang PL; Chang TH; Lo A; Ye XD; Lee MC; Liu K
Acta Anaesthesiol Taiwan; 2005 Dec; 43(4):197-204. PubMed ID: 16450593
[TBL] [Abstract][Full Text] [Related]
33. Activation of the hemostatic system during cardiopulmonary bypass.
Sniecinski RM; Chandler WL
Anesth Analg; 2011 Dec; 113(6):1319-33. PubMed ID: 22003219
[TBL] [Abstract][Full Text] [Related]
34. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery.
Kawamura T; Kadosaki M; Nara N; Kaise A; Suzuki H; Endo S; Wei J; Inada K
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):503-8. PubMed ID: 16884979
[TBL] [Abstract][Full Text] [Related]
35. Minimizing cardiopulmonary bypass attenuates myocardial damage after cardiac surgery.
Skrabal CA; Steinhoff G; Liebold A
ASAIO J; 2007; 53(1):32-5. PubMed ID: 17237646
[TBL] [Abstract][Full Text] [Related]
36. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
[TBL] [Abstract][Full Text] [Related]
37. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
Smith PK; Carrier M; Chen JC; Haverich A; Levy JH; Menasché P; Shernan SK; Van de Werf F; Adams PX; Todaro TG; Verrier E
Ann Thorac Surg; 2006 Sep; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
[TBL] [Abstract][Full Text] [Related]
38. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
[TBL] [Abstract][Full Text] [Related]
39. Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution.
Ohata T; Mitsuno M; Yamamura M; Tanaka H; Kobayashi Y; Ryomoto M; Yoshioka Y; Tsujiya N; Miyamoto Y
ASAIO J; 2008; 54(2):207-9. PubMed ID: 18356657
[TBL] [Abstract][Full Text] [Related]
40. Studies on the involvement of bradykinin using enalapril and 2-mercaptoethanol in ischemia-reperfusion induced myocardial infarction in albino rats.
Akula A; Veeravalli KK; Kota MK; Routhu KV
Pharmazie; 2003 Dec; 58(12):906-9. PubMed ID: 14703971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
